Study on GLP-1s and Breast Cancer ‘Too Good to Be True’?

(MedPage Today) — Use of GLP-1 receptor agonists in breast cancer patients was linked to lower mortality and recurrence risk in a retrospective study, but experts are questioning the quality of the underlying data. At 10 years, the risk of all…